These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9282790)

  • 1. The use of two different APC resistance assay systems provides optimal sensitivity and specificity for diagnosing genetic APC resistance.
    Solano C; Hogg AL; Saal RJ; Scott DC; Cobcroft RG
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):268-73. PubMed ID: 9282790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
    Ivey LM; Thom JY; Ivey JG; Baker RI
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C.
    Kraus M; Zander N; Fickenscher K
    Thromb Res; 1995 Nov; 80(3):255-64. PubMed ID: 8578552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.
    van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K
    Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma.
    Kapiotis S; Quehenberger P; Jilma B; Handler S; Pabinger-Fasching I; Mannhalter C; Speiser W
    Am J Clin Pathol; 1996 Nov; 106(5):588-93. PubMed ID: 8929467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutation.
    Aboud MR; Ma DD
    Br J Haematol; 1997 Jun; 97(4):798-803. PubMed ID: 9217178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified APC-resistance test: variable ratios with respect to source of factor V-deficient plasma.
    Ts'ao C; Neofotistos D; Oropeza M; Vahabinejad S; Finn WG
    Am J Hematol; 1997 Mar; 54(3):214-8. PubMed ID: 9067500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting APC-resistant factor V: a functional method without plasma dilution.
    Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood screening test for factor V Leiden using a Russell viper venom time-based assay.
    Akhtar MS; Blair AJ; King TC; Sweeney JD
    Am J Clin Pathol; 1998 Apr; 109(4):387-91. PubMed ID: 9535390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.
    Bokarewa MI; Bremme K; Falk G; Sten-Linder M; Egberg N; Blombäck M
    Thromb Res; 1995 May; 78(3):193-200. PubMed ID: 7631299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden-dependent APC resistance: improved sensitivity and specificity of the APC resistance test by plasma dilution in factor V-depleted plasma.
    Gouault-Heilmann M; Leroy-Matheron C
    Thromb Res; 1996 May; 82(3):281-3. PubMed ID: 8732632
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma.
    Strobl FJ; Hoffman S; Huber S; Williams EC; Voelkerding KV
    Arch Pathol Lab Med; 1998 May; 122(5):430-3. PubMed ID: 9593344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved test to identify aPC-resistant factor V-Leiden.
    Preda L; Erba N; Figini S; Carniti GC; Rossi E
    Thromb Res; 1997 Jun; 86(6):461-8. PubMed ID: 9219326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APC-resistance as measured by a Textarin time assay: comparison to the APTT-based method.
    Hoagland LE; Triplett DA; Peng F; Barna L
    Thromb Res; 1996 Sep; 83(5):363-73. PubMed ID: 8873345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients.
    Montes MA; Fox EA; Longtine JA; Dorfman DM
    Arch Pathol Lab Med; 1998 Apr; 122(4):325-9. PubMed ID: 9648899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C resistance as measured by residual factor V after Russell's viper venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controls.
    Zangari M; Berno T; Zhan F; Boucher KM; Tricot G; Fink L
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):420-3. PubMed ID: 21537162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation.
    de Ronde H; Bertina RM
    Blood Coagul Fibrinolysis; 1999 Jan; 10(1):7-17. PubMed ID: 10070830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.